1.Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer.

Xiang LING ; Wenjie WU ; Li YAN ; Leslie CURTIN ; Melanie M FARRAUTO ; Sandra SEXTON ; Anmbreen JAMROZE ; Changjun YU ; Christos FOUNTZILAS ; Dean G TANG ; Fengzhi LI

Journal of Pharmaceutical Analysis 2024;14(11):101001-101001